We are live on ! Find out more
CPIX icon

Cumberland Pharmaceuticals

26 hedge funds and large institutions have $13.2M invested in Cumberland Pharmaceuticals in 2021 Q4 according to their latest regulatory filings, with 7 funds opening new positions, 5 increasing their positions, 7 reducing their positions, and 4 closing their positions.

New
Increased
Maintained
Reduced
Closed

78% more capital invested

Capital invested by funds: $7.43M → $13.2M (+$5.8M)

75% more first-time investments, than exits

New positions opened: 7 | Existing positions closed: 4

13% more funds holding

Funds holding: 2326 (+3)

0.61% more ownership

Funds ownership: 18.6%19.21% (+0.61%)

29% less repeat investments, than reductions

Existing positions increased: 5 | Existing positions reduced: 7

Holders
26
Holders Change
+3
Holders Change %
+13.04%
% of All Funds
0.4%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
7
Increased
5
Reduced
7
Closed
4
Calls
$144K
Puts
Net Calls
+$144K
Net Calls Change
+$144K
Name Holding Trade Value Shares
Change
Change in
Stake
Russell Investments Group
26
Russell Investments Group
United Kingdom
-$13K -5,198 Closed
UBS Group
27
UBS Group
Switzerland
-$5K -1,933 Closed
Bank of America
28
Bank of America
North Carolina
+$68 +20 +19%

CPIX Hedge Fund Activity: Q4 2021 in Review

26 of the 6,498 institutional investors tracked by Wall St. Rank reported a position in Cumberland Pharmaceuticals (CPIX) for Q4 2021, worth a combined $13.2M — up 78% from $7.43M a quarter earlier.

Buyers outnumbered sellers: 7 funds opened new CPIX positions and 4 closed out — a net gain of 3 holders — while 5 added to existing stakes and 7 trimmed.

The largest buyer was Two Sigma Investments, opening a new position worth an estimated $283K. The largest seller was BlackRock, cutting an estimated $666K.

  • 26 institutional investors held Cumberland Pharmaceuticals (CPIX) as of Q4 2021, up from 23 in Q3 2021.
  • Funds reported $13.2M of Cumberland Pharmaceuticals stock for Q4 2021, up 78% quarter-over-quarter.
  • 7 funds opened new Cumberland Pharmaceuticals positions in Q4 2021 and 4 closed out, a net change of +3 holders.
  • The largest Cumberland Pharmaceuticals buyer in Q4 2021 was Two Sigma Investments, an estimated $283K added.
  • The largest Cumberland Pharmaceuticals seller in Q4 2021 was BlackRock, an estimated $666K sold.

Based on aggregated 13F filings for Q4 2021.